WASHINGTON – Senate lawmakers are set to unveil draft legislation as soon as Monday that will reform the FDA’s regulation of dietary supplements, cosmetic products, and certain lab-based tests, three lobbyists and a senior aide on the Senate health committee confirmed to STAT.
The policies will be included in the Senate Health, Education, Labor and Pensions Committee’s version of the legislation that sets out the fees industry pays to have the Food and Drug Administration regulate their products, known as user fee reauthorization legislation. The current funding agreement expires at the end of September.
The reforms would deliver on a number of long-sought changes meant to strengthen the FDA’s notably lax oversight over these products. But the committee has not released the text of the package, which could change as negotiations stretch into the weekend. A separate House version of the user fee legislation does not include any of the proposed cosmetics, supplement, or lab-test reforms.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
